Authors say findings highlight need to screen all teens for suicide risk and access to firearms
Vaccine Effectiveness Modest for Children, Teens During Omicron
BNT162b2 vaccine effectiveness against symptomatic infection modest and declined rapidly, was higher after booster dose in teens
BNT162b2 Prevents Critical COVID-19 in Children and Adolescents
During omicron-predominant period, effectiveness of two doses against hospitalization 68 percent for children, 40 percent for adolescents
Mental Health Among High School Students Explored During COVID-19
Students who felt close to someone at school had lower prevalence of poor mental health, had considered or attempted suicide
Immune Response to SARS-CoV-2 Infection Persists in Children
Ninety-six percent of those with evidence of nucleocapsid antibodies at baseline still had antibodies more than six months later
Vaccination Reduces Incidence of SARS-CoV-2 Among Adolescents
Vaccine effectiveness was 87.8 and 89.1 percent against documented and symptomatic infection, respectively
Vaccine Effectiveness Lower for Teens With Predominant Omicron
VE increased for adolescents aged 16 to 17 years at seven or more days after a third booster dose during omicron predominance
Homologous Pfizer-BioNTech Booster Safe for Adolescents
Reactions to booster occur with similar frequency as after receipt of second vaccine dose, generally mild to moderate
AAN: Tic Severity in Teens Tied to Social Media Use During Pandemic
Increased use of social media during the COVID-19 pandemic reported in small survey of adolescents with tic disorders
One in Four Women Globally Experience Intimate Partner Violence
One in seven women reported experiencing violence in the past year